82% doctors in US prefer Ozempic(Wegovy) Pill - NOVO something big is shaking

Novo Nordisk's weight loss pill, the Ozempic(Wegovy)Pill, is preferred by American doctors over Eli Lilly's latest offering, the Foundayo weight loss pill.

This is written by pharmaceutical analyst Michael Shah from Bloomberg Intelligence, referring to a study conducted by Bloomberg's own analysis unit.[https://finans.dk/erhverv/ECE19276575/undersoegelse-novos-vaegttabspille-foretraekkes-af-laeger/](https://finans.dk/erhverv/ECE19276575/undersoegelse-novos-vaegttabspille-foretraekkes-af-laeger/)